UUID:D7967984- FEW-4355 -9232 -5354404AC939

 

 

TCGA-CC-ABHS-BlA-PR Redacted
||| ||l||||||||Illlllllllllllll|||||l||||||||||||||||||||||||||||||| I
III II I “III“ II II” Illllllllllllllll Illlllllllllllllllllllll _
Ill llllllllllll|||||||||||I||||||||||I|||||lIllllllllllllllll ________ __J
Clinical Case Report
(For Collection of Cancerous Tissue) I C190 '3)

Wwwvb, jwjoalmdﬂ- #752}:
6d: ﬁlls/12M. €220

Enformed Consent! 9b) ”lie/x}

I personally informed this patient that a snecimenis) would be collected to be used for research
purposes. I reviewed the .-

_ with. the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

 

 

Name of Physician or Study Coordinator Signature Date

 

{Clinical Information}

GENERAL TION
Date of Blrth {mm/ddlmv\

.A , . ‘ A“
(7;: f/Vﬁw ’: ‘

_ ‘ :7 a gender " - Blood Pressure Heart Raine
'2? Male '

 

 

HISTORY OF PRESENT ILLNESS
Chief Complaints: WWW: all Pam ‘m \ MOM ,‘ 7416:) 9/»

Symptoms: 17qu 59/} my )i inW..Log_§.

Clinical Findings:

 

 

 

 

Performance Scale (Karnofsky Score):
D 100 Asymptomatic 0 80-90 Symptomatic but Fully Ambulatory a 60-70 Symptomatic, in bed less than 50% of day
$40-50 Symptomatic, in bed more than 50% of day, but not bed ridden B 20-30 Bed Ridden

 

 

 

CURRENT MEDICATIONS
Dose Route

 

 

PAST MEDICAL HISTORY
Disorder Date Treatment

 

 

 

 

 

 

 

 

OB/GYN HISTORY
Menopausal Status Date of First Menses # of Pregnancies
El Pro-menopausal
E1 Peri-Menopausal Date of Last Menses # of Live Birth:
:1 Post-menopausal -
Birth Control: U Condom C! Oral Contraceptive U FUD El Hormone Replacement
CI Other: Therapy:

 

 

 

 

SOCIAL HISTORY
Hazards:

Duration

Alcohol

Current Status Duration
D YES NO

FAMILY MEDICAL-HISTORY

 

 

 

 

 

 

 

 

 

LAB DATA
Test Result ! Date [ Test Result Date
HIV ﬁlNegative :3 Positive: CEA Cl Negative D Positive:
Hep B ﬂNegative 1] Positive: CA 15-3 0 Negative D Positive:
Hep C iaNegative D Positive: CA 19-9 El Negative El Positive:
APP :3 Negative I‘P’Positive: PSA [:1 Negative [3 Positive:
Other. Cl Negative El Positive: Other. El Negative U Positive:

 

 

 

 

 

 

 

 

B/T Cell Markers:

 

 

DIAGNOSTIC STUDIES
Results-

CLINICAL DIAGNOSIS

Location

 

"/1 M 0 Stage: III C

 

[Treatment Informationl

SURGICAL TREATMENT

Date of PW ""“
i t

Tumor

of

Paipable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Location

T N M

NEOADJUVENT THERAPY
Dose Route

 

Pathology Form

 

Specimen Information!

 

 

 

 

 

 

 

 

 

 

 

 

 

Collected by: __ Date: ”' Time; ' 7 __
Preserved by: _ Date: ,‘Time:
SPECIMEN TYPE (# of samples provided)
Frozen Parafﬁn Biock BloodIScmmfPlasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
AL 2 A. 2.. A— Z
' Time to LNZ Time to Formaiin Time to LNZ ‘
min min min

 

 

 

 

 

PATHOLOGICAL DESCRIPTION

Tumor
Size Extension of Tumor Distance to NAT

cm ‘ cm

Nodes
# # Metastasized

Distant Metastasis
Location

ical
P72 N4 Ma Stage:ﬂ7'

(

ggm/aémﬂﬁ 5‘ (/mgag Ejmcjfazm o)

 

 

 

 

Consolidated Pathology Diagnosis

Cellular Differentiation:

 

Nuclear Grade:

 

[Final Pathology Report!

Histological magmmewmmmmdm.
Comments: b, €37! DV‘?¢ D3¢&70 ‘9an
L6.— £11. -— Catt/NW WHQHMJ 7‘? M

 

 

 

'oate

INTEGRATED REPORT OF FINDINGS BY COUABORATORS AND

 

